SlidesetViral Hepatitis and Liver DiseaseHEP DART 2017Establishment of functional control and normalization of liver function in HBeAg negative chronic HBV infection following combined therapy with REP 2139 or REP 2165, tenofovir disoproxil fumarate and pegylated interferon α-2a.- Dr. A. VaillantView Slideset
SlidesetViral Hepatitis and Liver DiseaseHEP DART 2017Validation of a novel Transient Elastography for the measurement of liver fibrosis- Dr. J. DongView Slideset
VMVeronica MillerPhDSlidesetViral Hepatitis and Liver DiseaseHEP DART 2017Regulatory landscape for NASH- Veronica MillerView Slideset
SlidesetViral Hepatitis and Liver DiseaseHEP DART 2017An Integrated Multidisciplinary Approach for Prediction of Fibrosis Progression and HCC Development in Chronic Hepatitis C Infected Patients Utilizing Genomics, Elastography, Imaging and Circulating Tumor Cells (not yet available)- Dr. E. ThomasView Slideset
SlidesetViral Hepatitis and Liver DiseaseHEP DART 2017Two Doses of HEPLISAV-B™, a Hepatitis B Vaccine with a TLR9 Adjuvant, Compared with Three Doses of Alum-Adjuvanted ENGERIX-B® in Adults Aged 18 -70 Years- Dr. R. HyerView Slideset
SlidesetViral Hepatitis and Liver DiseaseHEP DART 2017Evidence Supporting Liver Targeting of Tenofovir Exalidex (TXL)- Dr. R. FosterView Slideset
SlidesetViral Hepatitis and Liver DiseaseHEP DART 2017RNA Interference Screen Identified Farnesoid X Receptor (FXR) as a Host Dependency Factor for HBV Establishment in Primary Human Hepatocytes- Dr. S. GhoshView Slideset
SlidesetViral Hepatitis and Liver DiseaseHEP DART 2017Aramchol for NASH and beyond: From scientific rationale to clinical development- Carol BrosgartView Slideset
MHEManal Hamdy El-SayedMD, PhDSlidesetViral Hepatitis and Liver DiseaseHEP DART 2017The Effectiveness of Treatment for Chronic Hepatitis C (and Hepatitis B) in Pediatric Populations- Manal El-Sayed, MD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseHEP DART 2017Liver Directed Acetyl-CoA Carboxylase Inhibitor GS-0976 For NASH (not available)- Adrian RayView Slideset
SlidesetViral Hepatitis and Liver DiseaseHEP DART 2017Lessons learned towards a Vaccine and Functional Cure for HIV (not available)- Mario StevensonView Slideset
SlidesetViral Hepatitis and Liver DiseaseHEP DART 2017Seroclearance of HBsAg in Chronic Hepatitis B Virus Patients on Lamivudine, Tenofovir or Entecavir Therapy: A 10 Year Experience- Dr. S. OnoView Slideset
